Chitosan 500 mg Plus Chromium
On sale on the US market (according to the DSLD)
NOW, food supplement from the US market
Chitosan 500 mg Plus Chromium (NOW), a food supplement au code-barres 733739020260, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 600 µg a day according to the label (at most 2 servings a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Chitosan 500 mg Plus Chromium
Entered into DSLD on 22 April 2021. On sale on the US market (according to the DSLD).Same active composition.
Official label: Chitosan 500 mg Plus Chromium
Entered into DSLD on 24 May 2017. Withdrawn from the US market on 25 August 2023 (according to the DSLD).- Same quantity, different name: LipoSan Ultra Chitosan in this version; Chitosan on the displayed label (1.5 Gram(s))
Official label: Chitosan 500 mg Plus Chromium
Entered into DSLD on 23 February 2016. Withdrawn from the US market on 1 May 2017 (according to the DSLD).- Same quantity, different name: LipoSan Ultra Chitosan in this version; Chitosan on the displayed label (1.5 Gram(s))
Official label: Chitosan 500 mg Plus Chromium
Entered into DSLD on 29 December 2014. Withdrawn from the US market on 23 December 2015 (according to the DSLD).- Same quantity, different name: LipoSan Ultra Chitosan in this version; Chitosan on the displayed label (1.5 Gram(s))
Official label: Chitosan 500 mg Plus Chromium
Entered into DSLD on 27 October 2014. Withdrawn from the US market on 26 November 2014 (according to the DSLD).- Same quantity, different name: LipoSan Ultra Chitosan in this version; Chitosan on the displayed label (1.5 Gram(s))
Official label: Chitosan 500 mg Plus Chromium
Entered into DSLD on 25 October 2012. Withdrawn from the US market on 8 October 2014 (according to the DSLD).- Active ingredient added : LipoSan Ultra Chitosan (1.5 g)
- Active ingredient removed : Chitosan (1.5 Gram(s))
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Chitosan
Read the warning, when it applies and the studies cited
CHITOSAN
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Pittler et al. 1999).
Sources cited by Health Canada (1)
- Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double-blind trial of chitosan for body weight reduction. European Journal of Clinical Nutrition 1999;53(5):379-381. PubMed Randomised trial
Condition of application: All products (except for weight management).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Weight management.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Condition of application: All products.
Do not use if you have an allergy to seafood.
Condition of application: Weight management.
Do not use if you are pregnant (HC 2010).
Sources cited by Health Canada (2)
- HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
- SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moraru et al. 2018; Mhurchu et al. 2004; Pittler et al. 1999).
Sources cited by Health Canada (3)
- Mhurchu CN, Poppitt SD, McGill AT, Leahy FE, Bennett DA, Lin RB, Ormrod D, Ward L,Strik C, Rodgers A. (on behalf of the Effect of Chitosan on Health and Obesity (ECHO) Collaboration). The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. International Journal of Obesity 2004;28:1149-1156. PubMed Randomised trial
- Moraru C, Mincea MM, Frandes M, Timar B, Ostafe V. A Meta-Analysis on Randomised Controlled Clinical Trials Evaluating the Effect of the Dietary Supplement Chitosan on Weight Loss, Lipid Parameters and Blood Pressure. Medicina (Kaunas) 2018; 54(6):109. PubMed Meta-analysis
- Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double-blind trial of chitosan for body weight reduction. European Journal of Clinical Nutrition 1999;53(5):379-381. PubMed Randomised trial
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : NOW
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.